SEBI Clears 4 Major IPOs: Carlsberg India, TMC Transformers & Ujin Pharma Get Green Light
India’s capital markets regulator, the Securities and Exchange Board of India (SEBI), has officially granted approval to four prospective corporate issuers to launch their initial public offerings (IPOs). The newly cleared roster is headlined by Carlsberg India Limited—the domestic operating subsidiary of Denmark-headquartered brewing multinational Carlsberg Group. Joining the Danish beverage major on the approved list are electrical equipment manufacturer TMC Transformers (India) Limited, pharmaceutical developer Ujin Pharma Limited, and industrial manufacturer Matangi Rubber Limited, signaling an accelerating pipeline of primary market offerings across diverse industrial sectors.
Review Timeline: Approvals Processed Following In-Depth Regulatory Scrutiny
Regulatory filings show that the four companies submitted their preliminary draft red herring prospectuses (DRHP) to the market watchdog between May and July 2026. Following detailed evaluations regarding statutory disclosures, financial transparency, and corporate governance standards, SEBI finalized its observation letters between September 28 and October 1, 2026. Securing these regulatory observations represents the most critical pre-listing clearance, granting all four entities the mandate to initiate anchor investor engagements, roadshows, and final issue scheduling in accordance with statutory capital market norms.
Issue Breakdown: Pure Fresh Issue at TMC Transformers vs. OFS Mix at Ujin Pharma
The cleared public issues represent a balanced mix of fresh capital mobilization and promoter divestments. Carlsberg India had opted for the confidential pre-filing route on July 1 to safeguard its commercial valuation strategy while completing regulatory reviews. Meanwhile, TMC Transformers (India) Limited plans to raise ₹550 crore entirely through a fresh issuance of equity shares, with existing promoters retaining their stakes and no Offer for Sale (OFS) component involved. In contrast, Ujin Pharma Limited’s capital structure includes a fresh issue of 1.18 crore (11.8 million) new equity shares alongside an OFS tranche of 72.82 lakh shares offloaded by selling promoters. Matangi Rubber Limited has also obtained full regulatory clearance to commence its formal public issue rollout.
Listing Horizon: Next Steps as Companies Finalize Launch Dates
With SEBI’s formal observation letters secured, all four companies have crossed the primary regulatory threshold required to tap domestic equity investors. The issuers, in consultation with their lead merchant bankers, will now monitor secondary market conditions, determine price bands, and file their final Red Herring Prospectuses (RHP) with the Registrar of Companies (RoC). As domestic primary markets maintain robust appetite through the second half of the fiscal year, retail and institutional participants are closely monitoring these listings for fresh allocation opportunities.
